On Tuesday, Globus Medical Inc (NYSE: GMED) was 1.43% up from the session before settling in for the closing price of $83.90. A 52-week range for GMED has been $44.02 – $87.22.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 18.43% over the last five years. When this article was written, the company’s average yearly earnings per share was at 28.24%. With a float of $112.92 million, this company’s outstanding shares have now reached $113.47 million.
The firm has a total of 5000 workers. Let’s measure their productivity. In terms of profitability, gross margin is 54.53%, operating margin of 6.64%, and the pretax margin is 4.88%.
Globus Medical Inc (GMED) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Globus Medical Inc stocks. The insider ownership of Globus Medical Inc is 17.07%, while institutional ownership is 80.57%. The most recent insider transaction that took place on Dec 02 ’24, was worth 217,364. Before that another transaction happened on Nov 21 ’24, when Company’s Director sold 13,254 for $85.00, making the entire transaction worth $1,126,590. This insider now owns 172,713 shares in total.
Globus Medical Inc (GMED) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 28.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.07% during the next five years compared to -7.04% drop over the previous five years of trading.
Globus Medical Inc (NYSE: GMED) Trading Performance Indicators
You can see what Globus Medical Inc (GMED) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.68. Likewise, its price to free cash flow for the trailing twelve months is 39.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.66, a number that is poised to hit 0.73 in the next quarter and is forecasted to reach 3.42 in one year’s time.
Technical Analysis of Globus Medical Inc (GMED)
Analysing the last 5-days average volume posted by the [Globus Medical Inc, GMED], we can find that recorded value of 0.76 million was lower than the volume posted last year of 1.0 million. As of the previous 9 days, the stock’s Stochastic %D was 67.29%. Additionally, its Average True Range was 1.93.
During the past 100 days, Globus Medical Inc’s (GMED) raw stochastic average was set at 91.02%, which indicates a significant increase from 68.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 17.83% in the past 14 days, which was lower than the 27.91% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $76.51, while its 200-day Moving Average is $66.30. Now, the first resistance to watch is $86.33. This is followed by the second major resistance level at $87.55. The third major resistance level sits at $89.80. If the price goes on to break the first support level at $82.86, it is likely to go to the next support level at $80.61. Should the price break the second support level, the third support level stands at $79.39.
Globus Medical Inc (NYSE: GMED) Key Stats
There are 136,167K outstanding shares of the company, which has a market capitalization of 11.59 billion. As of now, sales total 1,568 M while income totals 122,870 K. Its latest quarter income was 625,710 K while its last quarter net income were 51,840 K.
